Funding to Help Further Clinical Development of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis Bullosa EXTON, Pa., Dec. 11, […]
Innovative technology improves CDI program effectiveness while engaging physicians in documentation that better reflects the level of care provided to […]
PORTLAND, Maine, Dec. 11, 2018 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]